|
1
|
Jonasch E, Gao J and Rathmell WK: Renal
cell carcinoma. BMJ. 349:g47972014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hollingsworth JM, Miller DC, Daignault S
and Hollenbeck BK: Five-year survival after surgical treatment for
kidney cancer: A population-based competing risk analysis. Cancer.
109:1763–1768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta K, Miller JD, Li JZ, Russell MW and
Charbonneau C: Epidemiologic and socioeconomic burden of metastatic
renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev.
34:193–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mourad WF, Dutcher J and Ennis RD:
State-of-the-art management of renal cell carcinoma. Am J Clin
Oncol. 37:498–505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Escudier B, Eisen T, Stadler WM, Szczylik
C, Oudard S, Staehler M, Negrier S, Chevreau C, Desai AA, Rolland
F, et al: Sorafenib for treatment of renal cell carcinoma: Final
efficacy and safety results of the phase III treatment approaches
in renal cancer global evaluation trial. J Clin Oncol.
27:3312–3318. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grote P, Wittler L, Hendrix D, Koch F,
Währisch S, Beisaw A, Macura K, Bläss G, Kellis M, Werber M and
Herrmann BG: The tissue-specific lncRNA Fendrr is an essential
regulator of heart and body wall development in the mouse. Dev
Cell. 24:206–214. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin
L, Chen WM, Han L, Zhang EB, Kong R, De W, et al: Decreased
expression of the long non-coding RNA FENDRR is associated with
poor prognosis in gastric cancer and FENDRR regulates gastric
cancer cell metastasis by affecting fibronectin1 expression. J
Hematol Oncol. 7:632014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen R, Li WX, Sun Y, Duan Y, Li Q, Zhang
AX, Hu JL, Wang YM and Gao YD: Comprehensive analysis of lncRNA and
mRNA expression profiles in lung cancer. Clin Lab. 63:313–320.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sauvageau M, Goff LA, Lodato S, Bonev B,
Groff AF, Gerhardinger C, Sanchez-Gomez DB, Hacisuleyman E, Li E,
Spence M, et al: Multiple knockout mouse models reveal lincRNAs are
required for life and brain development. Elife. 2:e017492013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grote P and Herrmann BG: The long
non-coding RNA Fendrr links epigenetic control mechanisms to gene
regulatory networks in mammalian embryogenesis. RNA Biol.
10:1579–1585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H and Men CP: Correlation of
increased expression of MicroRNA-155 in bladder cancer and
prognosis. Lab Med. 46:118–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fuhrman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He W, Cai Q, Sun F, Zhong G, Wang P, Liu
H, Luo J, Yu H, Huang J and Lin T: linc-UBC1 physically associates
with polycomb repressive complex 2 (PRC2) and acts as a negative
prognostic factor for lymph node metastasis and survival in bladder
cancer. Biochim Biophy Acta. 1832:1528–1537. 2013. View Article : Google Scholar
|
|
15
|
Li Q, Wu C, Song G, Zhang H, Shan B, Duan
Y and Wang Y: Genome-wide analysis of long noncoding RNA expression
profiles in human Xuanwei lung cancer. Clin Lab. 61:1515–1523.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vieira-Coimbra M, Henrique R and Jeronimo
C: New insights on chromatin modifiers and histone
post-translational modifications in renal cell tumours. Eur J Clin
Invest 45 (Suppl). 1:S16–S24. 2015. View Article : Google Scholar
|
|
17
|
Schuettengruber B, Chourrout D, Vervoort
M, Leblanc B and Cavalli G: Genome regulation by polycomb and
trithorax proteins. Cell. 128:735–745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schlesinger Y, Straussman R, Keshet I,
Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E,
Reubinoff BE, et al: Polycomb-mediated methylation on Lys27 of
histone H3 pre-marks genes for de novo methylation in cancer. Nat
Genetics. 39:232–236. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Chen Y, Geng H, Qi C, Liu Y and
Yue D: Overexpression of YB1 and EZH2 are associated with cancer
metastasis and poor prognosis in renal cell carcinomas. Tumour
Biol. 36:7159–7166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu L, Xu Z, Zhong L, Wang H, Jiang S,
Long Q, Xu J and Guo J: EZH2 promotes tumor cell migration and
invasion via epigenetic repression of E-cadherin in renal cell
carcinoma. BJU Int. 117:351–362. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu ZQ, Zhang L, Gao BS, Wan YG, Zhang XH,
Chen B, Wang YT, Sun N and Fu YW: EZH2 promotes tumor progression
by increasing VEGF expression in clear cell renal cell carcinoma.
Clin Transl Oncol. 17:41–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmitz SU, Grote P and Herrmann BG:
Mechanisms of long noncoding RNA function in development and
disease. Cell Mol Life Sci. 73:2491–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Z, He A, Wang D, Liu Y and Huang W:
Long noncoding RNA HOTTIP as a novel predictor of lymph node
metastasis and survival in human cancer: A systematic review and
meta-analysis. Oncotarget. 8:14126–14132. 2017.PubMed/NCBI
|
|
26
|
Jing W, Zhu M, Zhang XW, Pan ZY, Gao SS,
Zhou H, Qiu SL, Liang CZ and Tu JC: The significance of long
noncoding RNA H19 in lredicting progression and metastasis of
cancers: A Meta-Analysis. Biomed Res Int. 2016:59026782016.
View Article : Google Scholar : PubMed/NCBI
|
